GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,494.00p
   
  • Change Today:
      9.00p
  • 52 Week High: 1,671.00
  • 52 Week Low: 1,264.00
  • Currency: UK Pounds
  • Shares Issued: 4,097.13m
  • Volume: 5,213,223
  • Market Cap: £61,211m
  • RiskGrade: 129

Latest ShareCast News

Berenberg downgrades GSK to 'hold' ahead of product rollouts

By Iain Gilbert

Date: Tuesday 03 Jun 2025

(Sharecast News) - Analysts at Berenberg downgraded drugmaker GSK from 'buy' to 'hold' on Tuesday as it awaited upcoming product launches.

GSK Regulatory News

GSK - second tranche of share buyback programme 04-Jun-2025 07:00 RNS
Transaction in Own Shares 04-Jun-2025 07:00 RNS
Transaction in Own Shares 03-Jun-2025 07:00 RNS
Director/PDMR Shareholding 02-Jun-2025 15:30 RNS
Total Voting Rights 02-Jun-2025 15:00 RNS

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,494.00p
Change Today 9.00p
% Change 0.61 %
52 Week High 1,671.00
52 Week Low 1,264.00
Volume 5,213,223
Shares Issued 4,097.13m
Market Cap £61,211m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
55% below the market average55% below the market average55% below the market average55% below the market average55% below the market average
39.13% above the sector average39.13% above the sector average39.13% above the sector average39.13% above the sector average39.13% above the sector average
Price Trend
35.72% above the market average35.72% above the market average35.72% above the market average35.72% above the market average35.72% above the market average
56.52% above the sector average56.52% above the sector average56.52% above the sector average56.52% above the sector average56.52% above the sector average
Income
70.18% above the market average70.18% above the market average70.18% above the market average70.18% above the market average70.18% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
36.53% below the market average36.53% below the market average36.53% below the market average36.53% below the market average36.53% below the market average
44.83% below the sector average44.83% below the sector average44.83% below the sector average44.83% below the sector average44.83% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 14
Sell 3
Strong Sell 1
Total 24
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q1 Q4
Ex-Div 15-May-25 20-Feb-25
Paid 10-Jul-25 10-Apr-25
Amount 16.00p 16.00p

Trades for 04-Jun-2025

Time Volume / Share Price
16:28 10 @ 1,495.50p
15:30 0 @ 1,495.00p
15:30 0 @ 1,495.00p
15:30 0 @ 1,495.00p
16:48 19,422 @ 1,494.00p

GSK Key Personnel

CEO Emma Walmsley

Top of Page